Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A118G SNP and OPRM1 Gene Effects on Hydromorphone Abuse Potential
NCT02360371Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Apr 2015
- Primary completion
- May 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of hydromorphone in pain, sponsored by Johns Hopkins University. Primary endpoints: Visual Analog Ratings of HIGH and Visual Analog Ratings of DRUG EFFECT. Started Apr 2015; status: completed.
02
Drugs
hydromorphone
03
Conditions
pain
Beyond the preview
Go deeper on NCT02360371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02360371.